{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:54:59Z","timestamp":1790852099995,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"CNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"University of Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR14-CE12-0009"],"award-info":[{"award-number":["ANR14-CE12-0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-0030-INRT"],"award-info":[{"award-number":["ANR-10-LABX-0030-INRT"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Investissements d\u2019Avenir","award":["10-IDEX-0002"],"award-info":[{"award-number":["10-IDEX-0002"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtn.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T02:52:57Z","timestamp":1551235977000},"page":"246-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Allele-Specific CRISPR\/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes"],"prefix":"10.1016","volume":"16","author":[{"given":"Aymen","family":"Rabai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Reisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Reina-San-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mamchaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda S.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Nicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.02.019_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1566523215666150812115730","article-title":"Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfalls","volume":"15","author":"Trochet","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtn.2019.02.019_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/6986","article-title":"Spliceosome-mediated RNA trans-splicing as a tool for gene therapy","volume":"17","author":"Puttaraju","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.02.019_bib3","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1038\/mtna.2016.67","article-title":"Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing","volume":"5","author":"Trochet","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.02.019_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nmeth.2649","article-title":"Cas9 as a versatile tool for engineering biology","volume":"10","author":"Mali","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2019.02.019_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.02.019_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 Editing of the Mutant Huntingtin Allele In\u00a0Vitro and In\u00a0Vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.02.019_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/hmg\/ddx073","article-title":"Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation","volume":"26","author":"Yamamoto","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.02.019_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2014.226","article-title":"Efficient and allele-specific genome editing of disease loci in human iPSCs","volume":"23","author":"Smith","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.02.019_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2019.02.019_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ana.21235","article-title":"Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset","volume":"62","author":"Bitoun","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2019.02.019_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2019.02.019_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/humu.22067","article-title":"Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy","volume":"33","author":"B\u00f6hm","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2019.02.019_bib13","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1093\/hmg\/ddq413","article-title":"A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice","volume":"19","author":"Durieux","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.02.019_bib14","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/emboj.2010.187","article-title":"Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients","volume":"29","author":"Kenniston","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2019.02.019_bib15","doi-asserted-by":"crossref","first-page":"22753","DOI":"10.1074\/jbc.C110.130013","article-title":"Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers","volume":"285","author":"Wang","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.02.019_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrm1313","article-title":"The dynamin superfamily: universal membrane tubulation and fission molecules?","volume":"5","author":"Praefcke","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2019.02.019_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1083\/jcb.150.2.377","article-title":"A functional link between dynamin and the actin cytoskeleton at podosomes","volume":"150","author":"Ochoa","year":"2000","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2019.02.019_bib18","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/emboj.2010.249","article-title":"Direct dynamin-actin interactions regulate the actin cytoskeleton","volume":"29","author":"Gu","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2019.02.019_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(89)90027-5","article-title":"Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules","volume":"59","author":"Shpetner","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.02.019_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1083\/jcb.201306140","article-title":"Lipid droplet breakdown requires dynamin 2 for vesiculation of autolysosomal tubules in hepatocytes","volume":"203","author":"Schulze","year":"2013","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2019.02.019_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/humu.21086","article-title":"Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis","volume":"30","author":"Bitoun","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2019.02.019_bib22","doi-asserted-by":"crossref","first-page":"e27498","DOI":"10.1371\/journal.pone.0027498","article-title":"Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy","volume":"6","author":"Koutsopoulos","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.02.019_bib23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1600-0854.2011.01250.x","article-title":"Common membrane trafficking defects of disease-associated dynamin 2 mutations","volume":"12","author":"Liu","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.omtn.2019.02.019_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1600-0854.2012.01348.x","article-title":"A centronuclear myopathy: dynamin 2 mutation impairs autophagy in mice","volume":"13","author":"Durieux","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.omtn.2019.02.019_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.02.019_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/oxfordjournals.jbchem.a022349","article-title":"Dynamin II is involved in endocytosis but not in the formation of transport vesicles from the trans-Golgi network","volume":"125","author":"Kasai","year":"1999","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.omtn.2019.02.019_bib27","doi-asserted-by":"crossref","first-page":"e27498","DOI":"10.1371\/journal.pone.0027498","article-title":"Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy","volume":"6","author":"Koutsopoulos","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.02.019_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nprot.2014.046","article-title":"Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase","volume":"9","author":"Robertson","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2019.02.019_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/351583a0","article-title":"Multiple forms of dynamin are encoded by shibire, a Drosophila gene involved in endocytosis","volume":"351","author":"Chen","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.02.019_bib30","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1083\/jcb.143.7.1871","article-title":"Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms","volume":"143","author":"Altschuler","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2019.02.019_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.15252\/emmm.201707988","article-title":"Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy","volume":"10","author":"Trochet","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2019.02.019_bib32","first-page":"45","article-title":"Development of Research into Autophagic Lysosome Reformation","volume":"41","author":"Chen","year":"2018","journal-title":"Mol. Cells"},{"key":"10.1016\/j.omtn.2019.02.019_bib33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/cr.2016.101","article-title":"Genome editing with CRISPR\/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome","volume":"26","author":"Xie","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2019.02.019_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.02.019_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2019.02.019_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","article-title":"Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies","volume":"21","author":"Robb","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2019.02.019_bib37","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI71206","article-title":"Reducing dynamin 2 expression rescues X-linked centronuclear myopathy","volume":"124","author":"Cowling","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2019.02.019_bib38","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/ncomms15661","article-title":"Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice","volume":"8","author":"Tasfaout","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2019.02.019_bib39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ymthe.2018.02.008","article-title":"Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice","volume":"26","author":"Tasfaout","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.02.019_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.nmd.2007.01.019","article-title":"Impact on oxidative phosphorylation of immortalization with the telomerase gene","volume":"17","author":"Aur\u00e9","year":"2007","journal-title":"Neuromuscul. Disord."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119300502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T01:48:43Z","timestamp":1720576123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119300502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"alternative-id":["S2162253119300502"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.02.019","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allele-Specific CRISPR\/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}